Logo image of AKBA

AKEBIA THERAPEUTICS INC (AKBA) Stock Analyst Ratings

NASDAQ:AKBA - Nasdaq - US00972D1054 - Common Stock - Currency: USD

1.8  -0.11 (-5.76%)

After market: 1.8 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to AKBA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.31. This target is 306.11% above the current price.
AKBA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about AKBA.
In the previous month the buy percentage consensus was at a similar level.
AKBA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

AKBA Historical Analyst RatingsAKBA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 5 10 15

Price Target & Forecast

Price Low Median Mean High 1.804.047.657.3110.50 - 124.44% 325.00% 306.11% 483.33%

Related screens

AKBA Current Analyst RatingAKBA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-01-23 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-12 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-28 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-17 HC Wainwright & Co. Maintains Buy -> Buy
2023-09-27 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-28 HC Wainwright & Co. Upgrade Neutral -> Buy
2023-08-11 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-06-21 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-06-14 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-06-02 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-05-31 Piper Sandler Upgrade Neutral -> Overweight
2023-05-30 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-05-26 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-05-09 Needham Reiterate Neutral
2023-04-26 HC Wainwright & Co. Maintains Neutral
2023-03-31 HC Wainwright & Co. Reiterate Neutral
2023-03-10 HC Wainwright & Co. Reiterate Neutral
2023-02-22 HC Wainwright & Co. Maintains Neutral
2022-05-16 HC Wainwright & Co. Maintains Neutral
2021-11-11 HC Wainwright & Co. Maintains Buy
2021-03-08 Cantor Fitzgerald Initiate Overweight
2021-03-08 HC Wainwright & Co. Maintains Buy